We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Advanced Instruments Exhibits New Products and Technologies at AACC

By LabMedica International staff writers
Posted on 31 Jul 2018
Print article
Image: The Osmo1 single-sample micro-osmometer (Photo courtesy of Advanced Instruments).
Image: The Osmo1 single-sample micro-osmometer (Photo courtesy of Advanced Instruments).
Advanced Instruments (Norwood, MA, USA) exhibited its new Osmo1 single-sample micro-osmometer, alongside its full line of instrumentation for clinical laboratories, including the Anoxomat III jar system and GloCyte automated cell counter system, at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo. Advanced Instruments, a developer of scientific and analytical instruments for the clinical industry, provides solutions and support to the clinical laboratory market.

The new Osmo1 single-sample micro-osmometer can measure the osmolality of specimens, including urine, serum, plasma, stool, and other body fluids, and uses a small 20 μL sample size. It offers workflow efficiency, result security and integrity, connectivity, quality control, and audit control for today’s busy clinical laboratories.

The Anoxomat III is an easy-to-use jar system for microbiology laboratories with the ability to create anaerobic, microaerophilic, and custom environments – such as capnophilic – within a few minutes. The quality control process checks the jar to ensure that there is no leakage and the catalyst is working, and provides the end user with documentation that the jar is under the appropriate environment before the incubation starts. The Anoxomat system offers shorter test times, improved workflow, and reduced operational costs for laboratories.

The GloCyte automated cell counter system combines fluorescence and imaging technology to deliver highly accurate and precise counts of total nucleated cells (TNCs) and red blood cells (RBCs) in cerebrospinal fluid samples. It is the only system that is linear down to 0 cells/μL and has a limit of detection of 1 cell/μL for both RBC and TNC. The GloCyte system requires a small sample volume of only 30 micro liters per test, minimizes manual errors with LIS connectivity, and features a built in quality control system that ensures accurate and precise results.

"Advanced Instruments is committed to supporting patient care by providing innovative technologies that meet the needs of clinical laboratories while helping improve workflow efficiencies," said Byron Selman, CEO of Advanced Instruments. "We look forward to introducing lab techs, managers, and directors to the new products in our portfolio that can contribute to their future success."

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more